Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,303 | 5,343 | 9,397 | 13,213 | 11,233 |
| Receivables | N/A | N/A | 26,265 | 24,702 | 13,058 |
| Inventories | N/A | N/A | 6,517 | 3,910 | 5,544 |
| Other current assets | 26,930 | 26,822 | 0 | 0 | 0 |
| TOTAL | $28,909 | $32,165 | $43,787 | $43,632 | $35,687 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 71 | 168 | 534 |
| Investments And Advances | 1,242 | 0 | 0 | 0 | 0 |
| Intangibles | 0 | 0 | 9,232 | 6,848 | 2,345 |
| Other Non-Current Assets | 13,747 | 7,574 | 2,953 | 3,038 | 2,524 |
| TOTAL | $14,989 | $7,574 | $12,256 | $10,054 | $5,403 |
| Total Assets | $43,898 | $39,739 | $56,043 | $53,686 | $41,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 147 | 148 |
| Accounts payable and accrued liabilities | 4,030 | 738 | 19,847 | 21,126 | 9,473 |
| Accrued Expenses | 704 | 250 | 12,300 | 10,692 | 11,353 |
| Other current liabilities | 38,228 | 42,752 | N/A | N/A | N/A |
| TOTAL | $48,027 | $43,740 | $32,147 | $32,062 | $20,985 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 66 |
| Deferred Revenues | N/A | N/A | N/A | 31 | 11 |
| Other Non-Current Liabilities | 1,228 | 0 | 0 | 150 | 0 |
| TOTAL | $3,826 | $1,699 | $1,528 | $1,579 | $1,475 |
| Total Liabilities | $51,853 | $45,439 | $33,675 | $33,641 | $22,460 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,488 | 352 | 240 | 228 | 107 |
| Common Shares | 1 | 0 | 4 | 41 | 19 |
| Retained earnings | -304,265 | -283,608 | -249,960 | -249,870 | -234,805 |
| TOTAL | $-7,955 | $-5,700 | $22,368 | $20,045 | $18,630 |
| Total Liabilities And Equity | $43,898 | $39,739 | $56,043 | $53,686 | $41,090 |